Cointime

Bioabsorbable Therapeutics

company

About

Bioabsorbable Therapeutics, Inc. develops and commercializes medical devices for treating coronary and peripheral vascular diseases. Its

  • 11 - 50

Highlights

Total Funding Amount
$9M
Funding Rounds
1
Investors
2

Details

Last Funding Type
Series B
Last Funding Money Raised
$9M
Industries
Biotechnology,Health Care,Health Diagnostics,Medical Device
Founded date
Jan 1, 2004
Number Of Employee
11 - 50
Operating Status
Active

Bioabsorbable Therapeutics, Inc. develops and commercializes medical devices for treating coronary and peripheral vascular diseases. Its products include Whisper coronary stent system, a balloon-expandable fully absorbable coronary stent; and Unison Peripheral Stent System, a self-expanding fully absorbable peripheral stent. The company uses anti-inflammatory polymers to develop bioabsorbable coatings and stents. Bioabsorbable Therapeutics, Inc. was founded in 2004 and is based in Menlo Park, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$9M
Bioabsorbable Therapeutics has raised a total of $9M in funding over 2 rounds. Their latest funding was raised on May 9, 2007 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 9, 2007 Series B $9M 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
Bioabsorbable Therapeutics is funded by 2 investors. Teton Capital Advisers and ITX International Holdings are the most recent investors.
Investor Name Lead Investor Funding Round
Teton Capital Advisers — Series B
ITX International Holdings — Series B
Cointime
İçerikler
Şirket.